Recently, magnetic-based theranostic nanoparticle (MBTN) systems have been studied, researched, and applied extensively to detect and treat various diseases including cancer. Theranostic nanoparticles are advantageous in that the diagnosis and treatment of a disease can be performed in a single setting using combinational strategies of targeting, imaging, and/or therapy. Of these theranostic strategies, magnetic-based systems containing magnetic nanoparticles (MNPs) have gained popularity because of their unique ability to be used in magnetic resonance imaging, magnetic targeting, hyperthermia, and controlled drug release. To increase their effectiveness, MNPs have been decorated with a wide variety of materials to improve their biocompatibility, carry therapeutic payloads, encapsulate/bind imaging agents, and provide functional groups for conjugation of biomolecules that provide receptor-mediated targeting of the disease. This review summarizes recent patents involving various polymer coatings, imaging agents, therapeutic agents, targeting mechanisms, and applications along with the major requirements and challenges faced in using MBTN for disease management.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686518 | PMC |
| http://dx.doi.org/10.2174/1874764711306010007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cancer Stem Cells: Current Challenges and Future Perspectives.
Methods Mol Biol
March 2024
Department of Surgery, McMaster University, Hamilton, ON, Canada.
Despite major advances in health care including improved diagnostic tools, robust chemotherapeutic regimens, advent of precision, adjuvant and multimodal therapies, there is a major proportion of patients that still go on to experience tumor progression and recurrence. Cancer stem cells (CSCs) are shown to be responsible for tumor persistence and relapse. This subpopulation of cancer cells possess normal stem cell like traits of self-renewal, proliferation, and multilineage differentiation.
View Article and Find Full Text PDFMagnetic Nanoparticles for Biomedical Applications: From the Soul of the Earth to the Deep History of Ourselves.
ACS Appl Bio Mater
August 2021
IB-S - Institute for Research and Innovation on Bio-Sustainability, University of Minho, Braga 4710-057, Portugal.
Precisely engineered magnetic nanoparticles (MNPs) have been widely explored for applications including theragnostic platforms, drug delivery systems, biomaterial/device coatings, tissue engineering scaffolds, performance-enhanced therapeutic alternatives, and even in SARS-CoV-2 detection strips. Such popularity is due to their unique, challenging, and tailorable physicochemical/magnetic properties. Given the wide biomedical-related potential applications of MNPs, significant achievements have been reached and published (exponentially) in the last five years, both in synthesis and application tailoring.
View Article and Find Full Text PDFIn Vitro Magnetic Techniques for Investigating Cancer Progression.
Cancers (Basel)
September 2021
Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN 47907, USA.
Worldwide, there are currently around 18.1 million new cancer cases and 9.6 million cancer deaths yearly.
View Article and Find Full Text PDFMagnetostrictive-Piezoelectric-Triggered Nanocatalytic Tumor Therapy.
Nano Lett
August 2021
State Key Laboratory of High Performance Ceramics and Superfine Microstructures, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, P. R. China.
Magnetic-based theranostics feature a high efficiency, excellent tissue penetration, and minimal damage to normal tissues, are noninvasive, and are widely used in the diagnosis and therapy of clinical diseases. Herein, a conceptually novel magnetostrictive-piezoelectric nanocatalytic medicine (MPE-NCM) for tumor therapy is proposed by initiating an intratumoral magneto-driven and piezoelectric-catalyzed reaction using core-shell structured CoFeO-BiFeO magnetostrictive-piezoelectric nanoparticles (CFO-BFO NPs) under an alternating magnetic field. The CFO-BFO NPs catalyze the generation of cytotoxic reactive oxygen species (ROS): superoxide radicals (•O) and hydroxyl radicals (•OH).
View Article and Find Full Text PDFMagnetic Plasmon Networks Programmed by Molecular Self-Assembly.
Adv Mater
July 2019
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, 30322, USA.
Nanoscale manipulation of magnetic fields has been a long-term pursuit in plasmonics and metamaterials, as it can enable a range of appealing optical properties, such as high-sensitivity circular dichroism, directional scattering, and low-refractive-index materials. Inspired by the natural magnetism of aromatic molecules, the cyclic ring cluster of plasmonic nanoparticles (NPs) has been suggested as a promising architecture with induced unnatural magnetism, especially at visible frequencies. However, it remains challenging to assemble plasmonic NPs into complex networks exhibiting strong visible magnetism.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!